Emerging impact of quercetin in the treatment of prostate cancer

Soudeh Ghafouri-Fard1, Farnaz Aghazadeh Shabestari2, Saba Vaezi3

  • 1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Quercetin, a plant flavonoid, shows promise in preventing and treating prostate cancer by inducing cancer cell death and enhancing other therapies. It selectively targets neoplastic cells, offering a potential new avenue for prostate cancer management.

Area of Science:

  • * Phytochemistry and Cancer Biology
  • * Nutritional Oncology

Background:

  • * Quercetin, a flavonoid found in fruits and vegetables, possesses anti-inflammatory, antioxidant, and anticancer properties.
  • * It exhibits potential in suppressing cell cycle progression and inducing apoptosis in neoplastic cells, particularly relevant to prostate cancer.
  • * Quercetin may play a role in preventing prostate cancer by inhibiting key genes like the androgen receptor (AR) and prostate specific antigen (PSA).

Purpose of the Study:

  • * To review current research on the preventive and therapeutic applications of quercetin in prostate cancer.
  • * To highlight quercetin's selective cytotoxic effects on cancerous prostate cells compared to normal cells.
  • * To explore quercetin's mechanisms of action, including apoptosis induction and potential synergy with other treatments.

Main Methods:

  • * Review of in vitro and in vivo experimental data on quercetin's effects on prostate cancer.
  • * Analysis of studies investigating quercetin's impact on cell cycle regulation and apoptosis pathways.
  • * Examination of research on quercetin's interaction with prostate cancer-related genes and therapeutic agents.

Main Results:

  • * Quercetin demonstrates differential effects on normal versus neoplastic prostate cells, indicating specific cytotoxicity against cancer cells.
  • * Its mechanism involves the modulation of apoptosis-related proteins (Bax, Bcl-xL) and the activation of caspase cascades.
  • * Quercetin may enhance the efficacy of other prostate cancer treatments, such as TNF-related apoptosis-inducing ligand (TRAIL).

Conclusions:

  • * Quercetin exhibits significant potential as both a preventive and therapeutic agent for prostate cancer.
  • * Its ability to induce apoptosis and selectively target cancer cells warrants further investigation.
  • * Combination therapies involving quercetin may offer novel strategies to overcome treatment resistance in prostate cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K